Effects of antidyskinetic nicotine treatment on dopamine release in dorsal and ventral striatum.

•Nicotine treatment inhibited development of levodopa-induced dyskinesia in mice.•Antidyskinetic nicotine treatment reduced α6β2*-mediated dopamine release.•α4β2*-mediated dopamine release was unaffected by antidyskinetic nicotine treatment.•Nicotine treatment restored basal dopamine release in lesioned ventral striatum.